Equities
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.

  • Revenue in USD (TTM)23.31bn
  • Net income in USD852.28m
  • Incorporated2006
  • Employees109.92k
More ▼

Institutional shareholders

5.03%Per cent of shares held by top holders
HolderShares% Held
Pzena Investment Management LLCas of 31 Dec 202514.75m2.51%
Fiduciary Management, Inc.as of 31 Dec 20254.96m0.85%
Dodge & Coxas of 31 Dec 20253.83m0.65%
Todd Asset Management LLCas of 31 Dec 20251.29m0.22%
Morgan Stanley & Co. LLCas of 31 Dec 2025985.80k0.17%
Morgan Stanley & Co. International Plcas of 31 Dec 2025958.00k0.16%
Parametric Portfolio Associates LLCas of 31 Dec 2025942.19k0.16%
Teachers Retirement System of the State of Kentuckyas of 31 Dec 2025816.20k0.14%
Point72 Asset Management LPas of 30 Sep 2025534.00k0.09%
Goldman Sachs Asset Management LPas of 31 Dec 2025474.40k0.08%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.